MedPath

The immersive virtual memory task: application of immersive Virtual Reality to investigate spatial memory deficits in neurological disorders

Not Applicable
Recruiting
Registration Number
DRKS00024005
Lead Sponsor
Tagesklinik für Kognitive Neurologie, Universitätsklinikum Leipzig
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
35
Inclusion Criteria

Subjects of any gender with acquired brain injury aged between 18 and 80 years can participate in the planned study. The diagnosis must be confirmed according to the respective disease-specific diagnostic criteria. In addition, the willingness and ability to participate must be fulfilled and a written informed consent must be available. There must be sufficient knowledge of German, linguistic comprehension ability and adequate visual ability.

Exclusion Criteria

Subjects with acute psychosis, those suffering from dizziness symptoms or with a history of alcohol or drug abuse cannot participate. Furthermore, subjects who are incapable of giving consent, who lack consent to report any incidental findings, who do not give written consent to participate, or who withdraw consent may not participate. Furthermore, subjects suffering from epilepsy may only participate if the last epileptic seizure occurred more than two years ago and stable medication can be established. Participating women must not be pregnant, planning a pregnancy or breastfeeding.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(1) The newly developed VR task, the imVMT, is externally validated using neuropsychological test procedures to measure spatial memory. The primary outcome measure is the correlation between performance on the imVMT, measured by mean deviation error (MDE), and standardized neuropsychological test procedures (Rey-Osterrieth Complex Figure Test, immediate recall; Visual and Verbal Memory Test, City Map subtest, immediate recall).
Secondary Outcome Measures
NameTimeMethod
(2) Determination of convergent and divergent validity with further neuropsychological test procedures (e.g. Montreal Cognitive Assessment, Trail Making Test, Corsi Block Tapping) and investigation of specificity.<br>(3) Evaluation of the influence of the task variables number of objects (3, 5, 7 objects) and rotation (90°, 180°, 270°) on the MDE.<br>(4) Evaluation of the influence of the task variables number of objects (3, 5, 7 objects) and rotation (90°, 180°, 270°) on the processing time<br>(5) Investigation of feasibility and acceptance of the immersive VR task measured by questionnaires (Simulator Sickness Questionnaire, Motion Sickness Susceptibility Questionnaire) and behavioral observations.<br>(6) System evaluation of the immersive VR task in terms of immersion (Immersive Tendencies Questionnaire, Presence, (Presence Questionnaire. Self-Presence Questionnaire), motivation and usability (VRUSE).
© Copyright 2025. All Rights Reserved by MedPath